MENU
BCAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioAtla (BCAB) Ownership - Who owns BioAtla?
BioAtla Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
26.68M
P/E Ratio
N/A
Total Cash
32.36M
Projected Growth
N/A
Total Debt
554K
Revenue
11M
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
0.55
Total Debt/Equity
N/A
Revenue/Share
0.22 USD as % of share price
Fundamentals
BCAB
Capitalization
26.7M
P/E Ratio
N/A
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
32.4M
Total Cash/Share
0.55
Total Debt
554K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.22%
Revenue
11M
ROE
N/A
Book Value
547K
P/B Ratio
50.76
Cash Flow
N/A
Earnings
-1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
2.35
Current Revenue Per Employee
169230.77
Dividends Per Share - Security
N/A
EBITDA
-66.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-97.07
Shares Held By Institutions
14.3M
Shares Outstanding - Current
58.4M
Total Liabilities
37.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-22.750
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com